Stocks
Veracyte, Inc.VCYT
NASDAQHealthcareBiotechnology$32.13+3.88%
Develops genomic diagnostic tests used by physicians to guide cancer diagnosis and treatment decisions. Its portfolio includes molecular tests for thyroid, prostate, breast, and other cancers, with products such as Afirma and Decipher used to help determine disease risk and appropriate care pathways...
Market Cap: $2.6B52W Range: $22.61 – $50.71
Congressional Interest in Veracyte, Inc. (VCYT)
3 members of Congress have disclosed 13 trades in Veracyte, Inc. (VCYT), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
3
Buys
6
Sells
7
Who in Congress Is Trading VCYT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-11-12 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-06-16 | Gilbert Cisneros | buy | $1K – $15K |